News
2h
Asianet Newsable on MSNHims & Hers Faces Retail Skepticism After Layoffs, FDA Ban on Compounded WegovyRetail investor sentiment around Hims & Hers Health remained negative over the weekend after the telehealth firm confirmed it ...
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
Scientists found brain cells behind semaglutide’s weight-loss power—and they don’t cause the nasty side effects.
6d
MedPage Today on MSNEnd of Compounded Semaglutide; 464M Teens Will Have Obesity; GLP-1 Scripts SkyrocketA federal deadline ending the sale of compounded semaglutide (Ozempic, Wegovy) is now in effect after a similar one for ...
Researchers have found in a new cohort study that semaglutide offers significant protection against osteoporosis and gout in ...
A San Antonio weight loss clinic owner is encouraging consumers of the GLP-1 drug semaglutide not to panic now that the FDA ...
Dr Reddy's Laboratories had received the manufacturing licence for semaglutide in December 2024 and it began production in ...
GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...
In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...
Legal battle over Novo Nordisk's semaglutide drug in India, with DRL, raises concerns over patent infringement and drug ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results